RJR-2531

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRJR-2531
Drug Alias NameRJR-2531
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors antagonists
TargetsNicotinic receptors
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesR.J. Reynolds Tobacco Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesR.J. Reynolds Tobacco Company
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A